Evidence map›Paper›PMID 42558260›Full record

ReviewFrontiers in immunology2026

"From inflammation to fibrosis: a proposed role of mucosal-associated invariant T cells in lichen sclerosus - a conceptual framework".

Marta Kasprowicz-Furmańczyk, Agnieszka Owczarczyk-Saczonek

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Marta Kasprowicz-FurmańczykSchool of Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland.
Agnieszka Owczarczyk-SaczonekSchool of Medicine, Collegium Medicum, University of Warmia and Mazury, Olsztyn, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lichen sclerosus (LS) is a chronic inflammatory and fibrosing dermatosis with a well-documented autoimmune background and a dominant Th1/Th17-driven immune response. Despite growing insight into its immunopathogenesis, the mechanisms linking persistent inflammation to progressive fibrosis remain unclear. Mucosal-associated invariant T cells (MAIT cells) are innate-like lymphocytes enriched in epithelial tissues, characterized by rapid activation and robust production of proinflammatory cytokines. Although alterations in MAIT cells frequency and function have been described in autoimmune and fibrotic disorders, their role in LS has not yet been elucidated. This review integrates current knowledge on MAIT cells biology and proposes a conceptual framework for their potential involvement in LS, largely based on extrapolation from studies in other inflammatory and fibrotic conditions. We hypothesize that MAIT cells may contribute to disease progression by amplifying Th1/Th17 responses, promoting epithelial damage and indirectly supporting fibroblast activation through cytokine-mediated pathways, including the TGF-β axis. Furthermore, their responsiveness to microbial-derived ligands and inflammatory cytokines suggests a role in sustaining chronic immune activation within a dysregulated tissue microenvironment. Under chronic inflammatory conditions, MAIT cells may shift toward a proinflammatory and profibrotic phenotype, thereby contributing to the transition from inflammation to fibrosis. This hypothesis-generating framework requires experimental validation but may provide new insights into LS pathogenesis and potential therapeutic targets.

Indexed as

InflammationLichen Sclerosus et AtrophicusMucosal-Associated Invariant T CellsAnimalsCytokinesFibrosisHumansCytokinesfibrosing diseaseinflammatory diseaselichen sclerosusMAIT cellsmucosal-associated invariant T cells

Identifiers

PMID42558260
PMCPMC13437352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.